<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="KO" article-type="case-report">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Korean Dent Soc Anesthesiol</journal-id>
<journal-id journal-id-type="publisher-id">JKDSA</journal-id>
<journal-title-group>
<journal-title>Journal of the Korean Dental Society of Anesthesiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1598-4044</issn>
<issn pub-type="epub">2383-7039</issn>
<publisher>
<publisher-name>The Korean Dental Society of Anesthesiology</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.17245/jkdsa.2010.10.1.13</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Bruxism and Oromandibular Dystonia after Brain Injury Treated with Botulinum Toxin A and Occlusal Appliance: A Case Report</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>tae-wan</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Baek</surname>
<given-names>Kwangwoo</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Song</surname>
<given-names>Seung-Il</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

</contrib-group>

<aff id="A1">Department of Dentistry, School of Medicine, Ajou University, Suwon, Korea.</aff>

<author-notes>
<corresp>Corresponding Author: (<email>seungilsong@hanmail.net</email>)</corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>06</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>05</month>
<year>2016</year>
</pub-date>
<volume>10</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>19</lpage>

<history>
<date date-type="received">
<day>25</day>
<month>03</month>
<year>2010</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>06</month>
<year>2010</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>06</month>
<year>2010</year>
</date>
</history>

<permissions>
<copyright-statement>Copyright &#x00A9; 2010 Journal of the Korean Dental Society of Anesthesiology</copyright-statement>
<copyright-year>2010</copyright-year>
<license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink"  xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>

<abstract>
<p>Bruxism is nonfunctional jaw movement that includes clenching, grinding and gnashing of teeth. It usually occurs during sleep, but with functional abnormality of brain, it can be seen during consciousness. Oromandibular dystonia (OMD) can involve the masticatory, lower facial, and tongue muscles and may result in trismus, bruxism, involuntary jaw opening or closure, and involuntary tongue movement. Its prevalence in the general population is 21%, but its incidence after brain injury is unknown, Untreated, bruxism and OMD cause masseter hypertrophy, headache, temporomandibular joint destruction and total dental wear. We report a case of successful treatment of bruxism and OMD after brain injury treated with botulinum toxin A and occlusal appliance. The patient was a 59-year-old man with operation history of frontal craniotomy and removal of malformed vessel secondary to cerebral arteriovenous malfomation. We injected with a total 60 units of botulinum toxin A each masseteric muscle and took impression for occlusal appliance fabrication under general anesthesia. On follow up 2 weeks and 2 months, the patient remained almost free of bruxism. We propose that botulinum toxin A and occlusal appliances be considered as a treatment for bruxism and OMD after brain injury.</p>
</abstract>

<kwd-group>
<kwd>Botulinum toxin A (BTX-A)</kwd>
<kwd>Brain injury</kwd>
<kwd>Bruxism</kwd>
<kwd>Occlusal appliance</kwd>
<kwd>Oromandibular dystonia (OMD)
</kwd>
</kwd-group>

</article-meta>
</front>

</article>